Chemical analysis and simulated pyrolysis of tobacco heating system 2.2 compared to conventional cigarettes

Nicotine and Tobacco Research

Volumn 21, Issue 1, 2019, Pages 111-118

  Li, Xiangyu ^a   Luo, Yanbo ^b   Jiang, Xingyi ^c   Zhang, Hongfei ^d   Zhu, Fengpeng ^d   Hu, Shaodong ^e   Hou, Hongwei ^f   Hu, Qingyuan ^g   Pang, Yongqiang ^f  

^a TSINGHUA UNIVERSITY   (China)

^b WUHAN UNIVERSITY   (China)

^c HENAN UNIVERSITY OF TECHNOLOGY   (China)

^d ZHENGZHOU UNIVERSITY OF LIGHT INDUSTRY   (China)

^e SICHUAN UNIVERSITY   (China)

^f UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

^g ANHUI INSTITUTE OF OPTICS AND FINE MECHANICS   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIA; AROMATIC AMINE; CARBON MONOXIDE; CARBONYL DERIVATIVE; CHLORIDE; GLYCEROL; HYDROGEN CYANIDE; NICOTINE; NITROSAMINE; PHENOL; POLYCYCLIC AROMATIC HYDROCARBON; PROPYLENE GLYCOL; TAR; VOLATILE ORGANIC COMPOUND; WATER;

ARTICLE; CHEMICAL ANALYSIS; MASS FRAGMENTOGRAPHY; PARTICULATE MATTER; PRIORITY JOURNAL; PYROLYSIS; SIMULATION; DRUG DELIVERY SYSTEM; EPIDEMIOLOGY; HARM REDUCTION; HUMAN; SMOKE; SMOKING; TOBACCO;

DRUG DELIVERY SYSTEMS; HARM REDUCTION; HUMANS; NICOTINE; PARTICULATE MATTER; PYROLYSIS; SMOKE; SMOKING; TOBACCO PRODUCTS; VOLATILE ORGANIC COMPOUNDS;

EID: 85053753615     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/nty005     Document Type: Article

References (51)

1. CDC (Centers for Disease Control and Preventiation). Cigarette smoking among adults-United States, 2000. Morbid Mortal W. 2002;51(29): 642.
2. HHS (U. S. Department of Health and Human Services). Reducing tobacco use: a report of the Surgeon General. Department of Health and Human Services, Centers for Disease Control and Preventation, National Center for Chronic Disease Preventation and Health Promotion, Office on Smoking and Health. Washington, DC: U.S. Government Printing Office, 2000.
3. Glasser AM, Collins L, Pearson JL, et al. Overview of Electronic Nicotine DeliverySystems:ASystematicReview.AmJPrevMed.2017;52(2):e33-e66. http://www.wsj.com/articles/e-cig-sales-rapidly-lose-steam-1447798921
4. Mickle T. E-cigarettes rapidly lose steam. The Wall Street Journal. Nov 17 2015 [Online].
5. Caputi TL. Heat-not-burn tobacco products are about to reach their boiling point. Tob Control. 2016. doi:10.1136/tobaccocontrol-2016-053264.
6. PMI. Investigator at the Consumer Analyst Group of New York (CAGNY) Conference. CAGNY Conference; February 22, 2017; Boca Raton, Florida.
7. Baker RR, Bishop LJ. The pyrolysis of tobacco ingredients. J Anal Appl pyrol. 2004;71(1):223-311.
8. Public Law 111-31,”The Family Smoking Prevention and Tobacco Control Act (FSPTCA).” 111th United States Congress: 2009.
9. Smith MR, Clark B, Ludicke F, et al. Evaluation of the Tobacco Heating System 2.2. Part 1: Description of the system and the scientific assessment program. Regul Toxicol Pharm: RTP. 2016;81(suppl 2):S17-S26.
10. Schaller JP, Keller D, Poget L, et al. Evaluation of the Tobacco Heating System 2.2. Part 2: Chemical composition, genotoxicity, cytotoxicity, and physical properties of the aerosol. Regul Toxicol Pharm: RTP. 2016;81(suppl 2):S27-S47.
11. Schaller JP, Pijnenburg JP, Ajithkumar A, Tricker AR. Evaluation of the Tobacco Heating System 2.2. Part 3: Influence of the tobacco blend on the formation of harmful and potentially harmful constituents of the Tobacco Heating System 2.2 aerosol. Regul Toxicol Pharm: RTP. 2016;81(suppl 2):S48-S58.
12. Wong ET, Kogel U, Veljkovic E, et al. Evaluation of the Tobacco Heating System 2.2. Part 4: 90-day OECD 413 rat inhalation study with systems toxicology endpoints demonstrates reduced exposure effects compared with cigarette smoke. Regul Toxicol Pharm: RTP. 2016;81(suppl 2):S59-S81.
13. Sewer A, Kogel U, Talikka M, et al. Evaluation of the Tobacco Heating System 2.2 (THS2.2). Part 5: microRNA expression from a 90-day rat inhalation study indicates that exposure to THS2.2 aerosol causes reduced effects on lung tissue compared with cigarette smoke. Regul Toxicol Pharm: RTP. 2016;81(suppl 2):S82-S92.
14. Oviedo A, Lebrun S, Kogel U, et al. Evaluation of the Tobacco Heating System 2.2. Part 6: 90-day OECD 413 rat inhalation study with systems toxicology endpoints demonstrates reduced exposure effects of a mentholated version compared with mentholated and non-mentholated cigarette smoke. Regul Toxicol Pharm: RTP. 2016; 18(suppl 2): S93-S122.
15. Kogel U, Titz B, Schlage WK, et al. Evaluation of the Tobacco Heating System 2.2. Part 7: Systems toxicological assessment of a mentholated version revealed reduced cellular and molecular exposure effects compared with mentholated and non-mentholated cigarette smoke. Regul Toxicol Pharm: RTP. 2016;81(suppl 2):S123-S138.
16. Haziza C, de La Bourdonnaye G, Skiada D, et al. Evaluation of the Tobacco Heating System 2.2. Part 8: 5-Day randomized reduced exposure clinical study in Poland. Regul Toxicol Pharm: RTP. 2016;81(suppl 2):S139-S150.
17. Martin F, Talikka M, Ivanov NV, Haziza C, Hoeng J, Peitsch MC. Evaluation of the tobacco heating system 2.2. Part 9: Application of systems pharmacology to identify exposure response markers in peripheral blood of smokers switching to THS2.2. Regul Toxicol Pharm: RTP. 2016;81(suppl 2):S151-S157.
18. Gonzalez-Suarez I, Martin F, Marescotti D, et al. In Vitro systems toxicology assessment of a candidate modified risk tobacco product shows reduced toxicity compared to that of a conventional cigarette. Chem Res Toxicol. 2016;29(1):3-18.
19. Ludicke F, Picavet P, Baker G, et al. Effects of switching to the Tobacco Heating System 2.2 Menthol, smoking abstinence, or continued cigarette smoking on biomarkers of exposure: a randomized, controlled, open-label, multicenter study in sequential confinement and ambulatory settings (Part 1). Nicotine & tobacco research: official journal of the Society for Research on Nicotine and Tobacco. 2018;20(2):161-172.
20. Ludicke F, Picavet P, Baker G, et al. Effects of switching to the Menthol Tobacco Heating System 2.2, smoking abstinence, or continued cigarette smoking on clinically relevant risk markers: a randomized, controlled, open-label, multicenter study in sequential confinement and ambulatory settings (Part 2). Nicotine & tobacco research: official journal of the Society for Research on Nicotine and Tobacco. 2018;20(2):173-182.
21. Auer R, Concha-Lozano N, Jacot-Sadowski I, Cornuz J, Berthet A. Heat-Not-Burn Tobacco Cigarettes. JAMA Intern Med. 2017;177(7):1050.
22. Glasgow RE, Gaglio B, Estabrooks PA, et al. Long-term results of a smoking reduction program. Med care. 2009;47(1):115-120.
23. Hart C, Gruer L, Bauld L. Does smoking reduction in midlife reduce mortality risk? Results of 2 long-term prospective cohort studies of men and women in Scotland. Am J Epidemiol. 2013;178(5):770-779.
24. ISO 4387:2000 Cigarettes - Determination of total and nicotine-free dry particulate matter using a routing analytical smoking machine. Switzerland: International Organization for Standardization Geneva; 2000.
25. Roemer E, Schramke H, Weiler H, et al. Mainstream Smoke Chemistry and in Vitro and In Vivo Toxicity of the Reference Cigarettes 3R4F and 2R4F. Beiträge Zur Tabakforschung. 2014;25(1):316-335.
26. McGrath TE, Brown AP, Meruva NK, Chan WG. Phenolic compound formation from the low temperature pyrolysis of tobacco. J Anal Appl Pyrol. 2009;84(2):170-178.
27. Czégény Z, Blazsó M, Várhegyi G, Jakab E, Liu C, Nappi L. Formation of selected toxicants from tobacco under different pyrolysis conditions. J Anal Appl Pyrol. 2009;85(1):47-53.
28. Cardoso C, Ataide CH. Analytical pyrolysis of tobacco residue: Effect of temperature and inorganic additives. J Anal Appl Pyrol. 2013;99:49-57.
29. ISO 3402:1999 Tobacco and tobacco products-atmosphere for conditioning and testing. Switzerland: International Organization for Standardization Geneva; 2015.
30. ISO 4387:2000 Cigarettes - Determination of total and nicotine-free dry particulate matter using a routine analytical smoking machine. Switzerland: International Organization for Standardization Geneva; 2016.
31. ISO 10315:2013 Cigarettes - Determination of nicotine in smoke condensates - Gas-chromatographic method. Switzerland: International Organization for Standardization Geneva; 2013.
32. ISO 8454:2007 Cigarettes - Determination of carbon monoxide in the vapour phase of cigarette smoke - NDIR method. Switzerland: International Organization for Standardization Geneva; 2016.
33. Wigand JS. Additives, Cigarette Design and Tobacco Product Regulation. Kobe, Japan: A Report to World Health Organizition Free Initiative Tobacco Product Regulation Group; 2006.
34. Reichenbach SE, Tian X, Cordero C, Tao Q. Features for non-targeted cross-sample analysis with comprehensive two-dimensional chromatography. J Chromatogr A. 2012;1226(4):140-148.
35. Reichenbach SE, Tian X, Tao Q, Ledford EB, Jr, Wu Z, Fiehn O. Informatics for cross-sample analysis with comprehensive two-dimensional gas chromatography and high-resolution mass spectrometry (GCxGC-HRMS). Talanta. 2011;83(4):1279-1288.
36. Baker RR. Formation of carbon oxides during tobacco combustion. J Anal Appl Pyrol 1983;4(4):297-334.
37. IARC. Agents classified by the IARC Monographs. Lyon, France: International Agency for Research on Cancer; 2012.
38. Lin YC, Cho J, Tompsett GA, Westmoreland PR, Huber GW. Kinetics and Mechanism of Cellulose Pyrolysis. J Phys Chem C. 2009;113(46):20097-20107.
39. Johnson WR, Kan JC. Mechanisms of hydrogen cyanide formation from the pyrolysis of amino acids and related compounds. J Org Chem. 1971;36(1):189-192.
40. Rodgman A. Studies of Polycyclic Aromatic Hydrocarbons in Cigarette Mainstream Smoke: Identification, Tobacco Precursors, Control of Levels: A Review. Beiträge Zur Tabakforschung. 2014;19(7):361-379.
41. Czégény Z, Blazsó M, Várhegyi G, Jakab E, Liu C, Nappi L. Formation of selected toxicants from tobacco under different pyrolysis conditions. J Anal Appl Pyrol. 2009;85(1-2):47-53.
42. Zuber J, D'Andres S, Boudoux R, Renaud J. TSNA Levels in the Mainstream Smoke of Simplified Blend Prototypes. Beiträge zur Tabakforschung International/Contributions to Tobacco Research. 2003;20(5):331-340.
43. Baker RR, Coburn S, Liu C, Tetteh J. Pyrolysis of saccharide tobacco ingredients: a TGA-FTIR investigation. J Anal Appl Pyrol. 2005;74(1):171-180.
44. Wang H, Guo J, Xia Q, et al. Study on formation mechanisms of ammonia and hydrogen cyanide during pyrolysis of proline. Tob Sci Tech. 2015;48 (suppl 1):S64-S70 http://www.tobst.cn/yckj/homeAction!downloadArticleFile.action?attachType=PDF&id=8244. Accessed April 2017.
45. Tayyarah R, Long GA. Comparison of select analytes in aerosol from e-cigarettes with smoke from conventional cigarettes and with ambient air. Regul. Toxicol. Pharm. 2014;70(3):704-710.
46. Goniewicz ML, Knysak J, Gawron M, et al. Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tob Control. 2014;23(2):133-139.
47. Farsalinos KE, Voudris V, Poulas K. E-cigarettes generate high levels of alde-hydes only in 'dry puff' conditions. Addiction. 2015;110(8):1352-1356.
48. Zhao J, Zhang Y, Sisler JD, et al. Assessment of reactive oxygen species generated by electronic cigarettes using acellular and cellular approaches. J Hazard Mater. 2017;344:549-557.
49. Farsalinos KE, Yannovits N, Sarri T, Voudris V, Poulas K. Nicotine delivery to the aerosol of a heat-not-burn tobacco product: comparison with a tobacco cigarette and e-cigarettes. Nicotine & tobacco research: official journal of the Society for Research on Nicotine and Tobacco. 2018;20(8):1004-1009.
50. Rowell TR, Tarran R. Will chronic e-cigarette use cause lung disease? American journal of physiology. Lung cellular and molecular physiology. 2015;309(12):L1398-1409.
51. Klus H, Boenkenimphius B, Müller L. Cigarette Mainstream Smoke: The Evolution of Methods and Devices for Generation, Exposure and Collection. Beiträge Zur Tabakforschung International/contributions to Tobacco Research. 2016;27(4):137-274.